18.16

3.86% -0.73

After Hours: 18.16

Zymeworks Inc. (ZYME)

Overview News Price History Option Chain Discussions Forecast

Zymeworks Inc. stock is traded at $18.16, with a volume of 551.65K. It is down -3.86% in the last 24 hours and up +7.20% over the past month. Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company's lead product candidate is ZW25, a novel bispecific antibody that is in Phase I clinical trial for the treatment of breast and gastric cancer. It is also developing ZW49, a bispecific antibody-drug conjugate that is in IND application stage. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Celgene Corporation and Celgene Alpine Investment Co. LLC; GlaxoSmithKline Intellectual Property Development Limited; Daiichi Sankyo Co., Ltd.; and Janssen Biotech, Inc., as well as a collaboration agreement with Celgene Corporation. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies targeting cytokine-receptor pathways. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada.

Previous Close:

$18.89

Open:

$18.38

24h Volume:

551.65K

Relative Volume:

0.87

Market Cap:

$1.37B

Revenue:

$122.87M

Net Income/Loss:

$-73.68M

P/E Ratio:

-18.52

EPS:

-0.9803

Net Cash Flow:

$-39.27M

1W Performance:

-5.91%

1M Performance:

+7.20%

6M Performance:

+40.12%

1Y Performance:

+23.04%

1-Day Range:

$18.00

$18.77

1-Week Range:

$18.00

$19.98

52-Week Range:

$9.03

$19.98

Zymeworks Inc. Stock (ZYME) Company Profile

Name

Zymeworks Inc.

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

604-678-1388

Address

1385 West 8th Avenue, Suite 540, Vancouver, BC

Employee

170

Twitter

@ZymeworksInc

Next Earnings Date

2024-10-31

Latest SEC Filings

ZYME's Discussions on Twitter

Compare ZYME with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ZYME Zymeworks Inc.	18.16	1.43B	122.87M	-73.68M	-39.27M	-0.9803
VRTX Vertex Pharmaceuticals Inc	421.67	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	628.00	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	423.47	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	831.48	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	182.77	39.72B	447.02M	-1.18B	-906.14M	-6.1812

Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-24-25	Resumed	Wells Fargo	Equal Weight
Oct-14-25	Upgrade	H.C. Wainwright	Neutral → Buy
Oct-10-25	Initiated	B. Riley Securities	Buy
May-20-25	Initiated	TD Cowen	Buy
Dec-16-24	Upgrade	JP Morgan	Neutral → Overweight
Nov-07-24	Upgrade	Leerink Partners	Market Perform → Outperform
Nov-01-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Mar-21-23	Resumed	Wells Fargo	Overweight
Jan-04-23	Reiterated	H.C. Wainwright	Neutral
Dec-20-22	Upgrade	Jefferies	Hold → Buy
Nov-01-22	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-21-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Oct-04-22	Resumed	Wells Fargo	Overweight
May-05-22	Upgrade	Guggenheim	Neutral → Buy
Mar-15-22	Initiated	Evercore ISI	Outperform
Dec-10-21	Upgrade	SVB Leerink	Mkt Perform → Outperform
Nov-17-21	Resumed	Guggenheim	Neutral
Oct-07-21	Initiated	Jefferies	Hold
Mar-31-21	Initiated	Credit Suisse	Outperform
Feb-25-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Feb-08-21	Resumed	H.C. Wainwright	Buy
Jan-25-21	Downgrade	Citigroup	Buy → Neutral
Sep-29-20	Resumed	JP Morgan	Neutral
Aug-06-20	Initiated	SVB Leerink	Outperform
Jan-10-20	Initiated	Wolfe Research	Outperform
Dec-09-19	Initiated	JP Morgan	Neutral
Nov-25-19	Initiated	H.C. Wainwright	Buy
Nov-20-19	Initiated	Guggenheim	Buy
Sep-30-19	Upgrade	Raymond James	Outperform → Strong Buy
Aug-30-19	Initiated	Stifel	Buy
Jul-18-19	Initiated	Deutsche Bank	Buy
May-11-18	Upgrade	Barclays	Underweight → Equal Weight
Mar-19-18	Initiated	Raymond James	Outperform

View All

Zymeworks Inc. Stock (ZYME) Latest News

06:04 AM

Zymeworks Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView

06:04 AM

08:09 AM

Why Zymeworks Inc. (ZA8) stock could outperform next yearWeekly Investment Recap & Stock Timing and Entry Methods - newser.com

08:09 AM

06:10 AM

Can Zymeworks Inc. stock rebound after recent weaknessMarket Performance Summary & Risk Managed Trade Strategies - newser.com

06:10 AM

05:47 AM

Applying Elliott Wave Theory to Zymeworks Inc.2025 Trade Ideas & Verified Short-Term Plans - newser.com

05:47 AM

05:07 AM

Will Zymeworks Inc. stock pay special dividends2025 Trading Recap & AI Forecast for Swing Trade Picks - newser.com

05:07 AM

04:57 AM

How Zymeworks Inc. stock compares to market leadersQuarterly Portfolio Review & Weekly Hot Stock Watchlists - newser.com

04:57 AM

04:09 AM

How moving averages guide Zymeworks Inc. tradingWeekly Trend Recap & Smart Money Movement Tracker - newser.com

04:09 AM

03:34 AM

AlphaQuest LLC Has $176,000 Stock Holdings in Zymeworks Inc. $ZYME - MarketBeat

03:34 AM

03:31 AM

Is Zymeworks Inc. stock bottoming outJuly 2025 Final Week & AI Driven Stock Movement Reports - newser.com

03:31 AM

03:19 AM

Published on: 2025-11-04 02:19:40 - newser.com

03:19 AM

02:22 AM

Is Zymeworks Inc. stock a contrarian buyJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com

02:22 AM

01:48 AM

Published on: 2025-11-04 00:48:32 - newser.com

01:48 AM

Nov 03, 2025

Is Zymeworks Inc. (ZA8) stock cheap vs fundamentals2025 Market Overview & Technical Pattern Based Signals - newser.com

Nov 03, 2025

How to use Fibonacci retracement on Zymeworks Inc.Portfolio Risk Summary & Reliable Price Action Trade Plans - newser.com

Nov 03, 2025

Published on: 2025-11-03 08:56:43 - newser.com

Nov 03, 2025

What technical patterns form on Zymeworks Inc. (ZA8) stock chartsBond Market & AI Driven Stock Movement Reports - newser.com

Nov 03, 2025

Will Zymeworks Inc. stock sustain high P E ratiosMarket Risk Report & Real-Time Market Trend Scan - newser.com

Nov 03, 2025

Will Zymeworks Inc. stock attract ESG investors2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com

Nov 03, 2025

Will Zymeworks Inc. stock gain from strong economyQuarterly Portfolio Report & Smart Swing Trading Techniques - newser.com

Nov 03, 2025

Is Zymeworks Inc. forming a bottoming baseMarket Volume Summary & Weekly High Conviction Ideas - newser.com

Nov 03, 2025

Nov 02, 2025

What sentiment indicators say about Zymeworks Inc. stockBond Market & Capital Protection Trading Alerts - newser.com

Nov 02, 2025

How Zymeworks Inc. (ZA8) stock performs in volatility spikesJuly 2025 Volume & Comprehensive Market Scan Reports - newser.com

Nov 02, 2025

HC Wainwright & Co. Upgrades Zymeworks (ZYME) - MSN

Nov 02, 2025

Custom strategy builders for tracking Zymeworks Inc.Trade Risk Assessment & Verified Swing Trading Watchlists - newser.com

Nov 02, 2025

How Zymeworks Inc. (ZA8) stock stacks up against competitors2025 Key Highlights & Capital Protection Trading Alerts - newser.com

Nov 02, 2025

Why Zymeworks Inc. stock is in analyst buy zoneWatch List & Verified Momentum Stock Alerts - newser.com

Nov 02, 2025

Nov 01, 2025

Is Zymeworks Inc. (ZA8) stock nearing a technical breakout2025 Price Targets & Smart Allocation Stock Reports - newser.com

Nov 01, 2025

Oct 31, 2025

Zymeworks, Inc. Hits New 52-Week High at $19.98 - Markets Mojo

Oct 31, 2025

Zymeworks Inc. (NASDAQ:ZYME) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Oct 31, 2025

Zymeworks (NASDAQ:ZYME) Reaches New 52-Week HighStill a Buy? - MarketBeat

Oct 31, 2025